David Ebersman is listed as an executive officer, director, and promoter on 13 SEC Form D filings by 3 issuers between Aug 2009 and Jan 2022: Lyra Health, Inc. (Burlingame, CA — industry reported as "Other" — 2018–2022; $235M reported sold to 33 investors), IRONWOOD PHARMACEUTICALS INC (Cambridge, MA — pharmaceuticals — 2009–2013; $175M reported sold to 18 investors) and CASTLIGHT HEALTH, INC. (San Francisco, CA — other health care — 2012; $100M reported sold to 35 investors).
What this means A repeat sponsor — 3 separate companies raised money with this person listed as executive officer, director, and promoter, over about 13 years. Across those companies the filings report $510M sold in total.
Listed alongside Bryan Roberts (13 shared filings), Bob Kocher (7 shared filings), Elaine Yang (7 shared filings), James Slavet (7 shared filings), CHRISTOPHER T. WALSH (5 shared filings) and 24 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around David. Each name links to their own page.
1 of the issuers belongs to the sponsor group Ironwood (2 issuers, $261.5M reported sold, 2009–2020).
What this means A sponsor group is one team that sets up a new company for each deal. Ironwood has 2 companies on file and $261.5M reported sold in total — the group page shows the whole track record in one place.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 13 public filings for David Ebersman and found 13 differences, 2 worth asking the sponsor about: Amount sold went down between filings; Form D filed 117 days after the first sale; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.